In vitro activities of a streptogramin (RP59500), three macrolides, and an azalide against four respiratory tract pathogens (Q35111191)

6 August 2017

title

In vitro activities of a streptogramin (RP59500), three macrolides, and an azalide against four respiratory tract pathogens (English)

1 reference

6 August 2017

1

Barry AL

1 reference

6 August 2017

2

Fuchs PC

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 January 1995

1 reference

Antimicrobial Agents and Chemotherapy

6 August 2017

published in

1 reference

6 August 2017

volume

39

1 reference

6 August 2017

issue

1

1 reference

6 August 2017

page(s)

238-240

1 reference

In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. Medical Centers in 1992 and 1993.

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162515

Erythromycin: a microbial and clinical perspective after 30 years of clinical use (1).

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162515

Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162515

New directions for macrolide antibiotics: pharmacokinetics and clinical efficacy

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162515

In vitro activity of RP 59500, a semisynthetic injectable pristinamycin, against staphylococci, streptococci, and enterococci

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162515

Activity of RP 59500, a new parenteral semisynthetic streptogramin, against staphylococci with various mechanisms of resistance to macrolide-lincosamide-streptogramin antibiotics.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162515

The in-vitro activity of new streptogramins, RP 59500, RP 57669 and RP 54476, alone and in combination

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162515

RP 59500, a new streptogramin highly active against recent isolates of North American staphylococci

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162515

Occurrence of macrolide-lincosamide-streptogramin resistances among staphylococcal clinical isolates at a university medical center. Is false susceptibility to new macrolides and clindamycin a contemporary clinical and in vitro testing problem?

27 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/7695313

12 December 2020

inferred from PubMed ID database lookup

Haemophilus test medium versus Mueller-Hinton broth with lysed horse blood for antimicrobial susceptibility testing of four bacterial species

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/7695313

12 December 2020

inferred from PubMed ID database lookup

In-vitro antibacterial activity of RP 59500, a semisynthetic streptogramin, against Streptococcus pneumoniae

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/7695313

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1128/AAC.39.1.238

1 reference

release_ctfmcdfotbdixb66s2xpgvk4ci

6 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ctfmcdfotbdixb66s2xpgvk4ci

24 November 2022

mapped directly with Wikidata item

PMC publication ID

162515

1 reference

6 August 2017

1 reference